Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

VanEck Pharmaceutical ETF (PPH) offers a lower expense ratio (0.36%) and higher dividend yield (2.00%), making it ideal for income-focused investors, while Invesco Pharmaceuticals ETF (PJP) delivered stronger 1-year returns (49.90% vs 27.10%) but has higher fees (0.57%). PPH provides global exposure with better 5-year performance, while PJP focuses exclusively on U.S. stocks and benefits from sector momentum like the GLP-1 weight loss trend.